Prostate Cancer Screening

I. Trends in prostate cancer screening
1) Overview of US Prostate Cancer Trends in the Era of PSA Screening Ruth Etzioni, MD, Roman Gulati, Angela Mariotto, PhD.
2) Trends in Prostate Cancer Screening: Overview of the UK Freddie C Hamdy, MD, Richard J Bryant, MD
3) Trends in prostate cancer screening: Canada Robert K Nam, MD, Laurence H Klotz, MD
4) Trends in prostate cancer screening: Europe Sanjai Addla, FRCS, Robert Djavan, MD, PhD

II. Prostate Specific Antigen
5) Evolution of Prostate Specific Antigen for screening Javier Hernandez, MD, MS, Edith Canby-Hagino, MD, MS
6) The performance characteristics of prostate specific antigen for prostate cancer screening Ian M. Thompson, MD, Donna P. Ankerst, PhD
7) The performance of PSA after a prior negative prostate biopsy Catherine M Tangen, Dr. PH
8) Subfractions and derivatives of total prostate specific antigen in the early detection of prostate cancer Alexander Haese, MD, PhD, Alan W Partin, MD, PhD
9) PSA velocity at presentation as a predictor of prostate cancer aggressiveness Jason A Efstathiou, MD, PhD, Anthony D'Amico, MD, PhD

III. Risk assessment for prostate cancer
10) Nomograms for prostate cancer Shahrokh F Shariat, MD, Mike W Kattan, MD
11) Artificial neural networks for optimizing prostate cancer risk prediction Felix K.-H. Chun, MD, Pierre I. Karakiewicz, MD
12) Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator Donna P Ankerst, PhD, Ian M Thompson, MD
13) Integration of risk assessment in prostate cancer screening Kadee Thompson, MD, Amanda Reed, MD, Dipen J Parekh, MD
14) Family history ofprostate cancer during rapidly increasing incidence Kari Hemminki, MD, Justo Lorenzo Bermelo, MD

IV. Recent biomarkers for prostate cancer
15) PSA Isoforms:[-2]proPSA Significant Adjunct to Free PSA Jeffrey E Tam
16) PCA3 Jack Groskopf, PhD, Jack Schalken, PhD, Harry Rittenhouse, PhD
17) Transcriptional profiling for prostate cancer biomarker identification

From the reviews of the second edition:"This compilation of 27 chapters written by well known urology experts covers a wide range of topics from trends in PSA screening to PSA isoforms ... .This book is most suitable for statisticians, scientists, or clinicians who wish to draw their own conclusions regarding PSA screening and related topics. ... This book is a superb resource for anyone interested in PSA screening ... . It is also an excellent reference for anyone interested in comparing the various studies and controversies from different healthcare systems ... ." (Jack H. Mydlo, Doody's Review Service, May, 2009)

From the reviews of the second edition:



"This compilation of 27 chapters written by well known urology experts covers a wide range of topics from trends in PSA screening to PSA isoforms ... .This book is most suitable for statisticians, scientists, or clinicians who wish to draw their own conclusions regarding PSA screening and related topics. ... This book is a superb resource for anyone interested in PSA screening ... . It is also an excellent reference for anyone interested in comparing the various studies and controversies from different healthcare systems ... ." (Jack H. Mydlo, Doody's Review Service, May, 2009)